Study S000998

GLP-1 Receptor Agonist Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07627191
Study type: INTERVENTIONAL
Allocation: NON_RANDOMIZED
Phase: EARLY_PHASE1
Masking: NONE
Status: RECRUITING
Enrollment: 30
Start: 2026-10-10
Primary completion: 2028-06-30
Lead sponsor: University of Arizona
Conditions: Pancreatic Cancer; Colorectal Cancer; Hepatocellular Carcinoma
Interventions: DRUG:GLP1-RA (semaglutide)
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Incidence of Treatment Emergent Adverse Events [Safety] attributed to GLP1-RA and/or its interaction with chemotherapy [Up to 6 months or at time of disease progression, whichever comes first]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.